Evaluation: Based on all recent filings, financial statements, and news.
See full evaluationCurrent Price
as of Dec 03, 2024$71.44
P/E Ratio
76.54
Market Cap
$2.4B
TransMedics Group, Inc. operates as a commercial stage medical technology company. The firm engages in the development and commercialization of organ care system platform. It focuses on the preservation of human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation. The company was founded by Waleed H. Hassanein in August 1998 and is headquartered in Andover, MA.
Overview
Trading Information
Company